| ID: 127883184 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr16:11946068-11946601 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (11852211..11852744) | | |
| ID: 127883183 | H3K4me1 hESC enhancer GRCh37_chr16:11916005-11916505 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (11822148..11822648) | | |
| ID: 127883182 | H3K4me1 hESC enhancer GRCh37_chr16:11915504-11916004 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (11821647..11822147) | | |
| ID: 127883181 | H3K27ac hESC enhancer GRCh37_chr16:11890813-11891350 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (11796957..11797541) | | |
| ID: 126862289 | BRD4-independent group 4 enhancer GRCh37_chr16:11944561-11945760 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (11850704..11852210) | | |
| ID: 106799840 | nonconserved acetylation island sequence 94 enhancer [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (11681219..11681575) | | |
| ID: 400500 | breast cancer anti-estrogen resistance 4 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (11819830..11828832, complement) | | 613746 |
| ID: 51061 | thioredoxin domain containing 11 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (11679083..11742857, complement) | EFP1 | 617792 |
| ID: 29066 | zinc finger CCCH-type containing 7A [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (11750597..11797258, complement) | HSPC055, ZC3H7, ZC3HDC7 | 619819 |
| ID: 26156 | ribosomal L1 domain containing 1 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (11833850..11851542, complement) | CSIG, L12, PBK1, UTP30 | 615874 |